These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 16246510

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Determination of age and gender differences in biochemical processes affecting the disposition of 2-butoxyethanol and its metabolites in mice and rats to improve PBPK modeling.
    Corley RA, Grant DM, Farris E, Weitz KK, Soelberg JJ, Thrall KD, Poet TS.
    Toxicol Lett; 2005 Mar 28; 156(1):127-61. PubMed ID: 15705493
    [Abstract] [Full Text] [Related]

  • 3. Physiologically based pharmacokinetics of 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in rats and humans.
    Corley RA, Bormett GA, Ghanayem BI.
    Toxicol Appl Pharmacol; 1994 Nov 28; 129(1):61-79. PubMed ID: 7974497
    [Abstract] [Full Text] [Related]

  • 4. Physiologically based pharmacokinetics and the dermal absorption of 2-butoxyethanol vapor by humans.
    Corley RA, Markham DA, Banks C, Delorme P, Masterman A, Houle JM.
    Fundam Appl Toxicol; 1997 Oct 28; 39(2):120-30. PubMed ID: 9344624
    [Abstract] [Full Text] [Related]

  • 5. Physiologically based modeling of 2-butoxyethanol disposition in rats following different routes of exposure.
    Shyr LJ, Sabourin PJ, Medinsky MA, Birnbaum LS, Henderson RF.
    Environ Res; 1993 Nov 28; 63(2):202-18. PubMed ID: 8243415
    [Abstract] [Full Text] [Related]

  • 6. A toxicokinetic study of inhaled ethylene glycol ethyl ether acetate and validation of a physiologically based pharmacokinetic model for rat and human.
    Gargas ML, Tyler TR, Sweeney LM, Corley RA, Weitz KK, Mast TJ, Paustenbach DJ, Hays SM.
    Toxicol Appl Pharmacol; 2000 May 15; 165(1):63-73. PubMed ID: 10814554
    [Abstract] [Full Text] [Related]

  • 7. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS.
    Chem Biol Interact; 2007 Mar 20; 166(1-3):352-9. PubMed ID: 17324392
    [Abstract] [Full Text] [Related]

  • 8. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
    Fisher JW, Mahle D, Abbas R.
    Toxicol Appl Pharmacol; 1998 Oct 20; 152(2):339-59. PubMed ID: 9853003
    [Abstract] [Full Text] [Related]

  • 9. Physiologically based pharmacokinetic model for chronic inhalation of 2-butoxyethanol.
    Lee KM, Dill JA, Chou BJ, Roycroft JH.
    Toxicol Appl Pharmacol; 1998 Dec 20; 153(2):211-26. PubMed ID: 9878592
    [Abstract] [Full Text] [Related]

  • 10. A human exposure study to investigate biological monitoring methods for 2-butoxyethanol.
    Jones K, Cocker J.
    Biomarkers; 2003 Dec 20; 8(5):360-70. PubMed ID: 14602521
    [Abstract] [Full Text] [Related]

  • 11. Biological monitoring of low-level 2-butoxyethanol exposure in decal transfer workers in bicycle manufacturing factories.
    Hung PC, Cheng SF, Liou SH, Tsai SW.
    Occup Environ Med; 2011 Oct 20; 68(10):777-82. PubMed ID: 21278143
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically based mathematical model.
    Clarke DO, Elswick BA, Welsch F, Conolly RB.
    Toxicol Appl Pharmacol; 1993 Aug 20; 121(2):239-52. PubMed ID: 8346541
    [Abstract] [Full Text] [Related]

  • 13. Percutaneous absorption and metabolism of 2-butoxyethanol in human volunteers: a microdialysis study.
    Korinth G, Jakasa I, Wellner T, Kezic S, Krüse J, Schaller KH.
    Toxicol Lett; 2007 Apr 25; 170(2):97-103. PubMed ID: 17412532
    [Abstract] [Full Text] [Related]

  • 14. Free and total urinary 2-butoxyacetic acid following dermal and inhalation exposure to 2-butoxyethanol in human volunteers.
    Kezic S, Meuling WJ, Jakasa I.
    Int Arch Occup Environ Health; 2004 Nov 25; 77(8):580-6. PubMed ID: 15688250
    [Abstract] [Full Text] [Related]

  • 15. Rat erythrocyte morphological changes after gavage dosing with 2-butoxyethanol: a comparison with the in vitro effects of butoxyacetic acid on rat and human erythrocytes.
    Udden MM.
    J Appl Toxicol; 2000 Nov 25; 20(5):381-7. PubMed ID: 11139168
    [Abstract] [Full Text] [Related]

  • 16. Metabolic basis of ethylene glycol monobutyl ether (2-butoxyethanol) toxicity: role of alcohol and aldehyde dehydrogenases.
    Ghanayem BI, Burka LT, Matthews HB.
    J Pharmacol Exp Ther; 1987 Jul 25; 242(1):222-31. PubMed ID: 3612528
    [Abstract] [Full Text] [Related]

  • 17. Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats.
    Hays SM, Elswick BA, Blumenthal GM, Welsch F, Conolly RB, Gargas ML.
    Toxicol Appl Pharmacol; 2000 Feb 15; 163(1):67-74. PubMed ID: 10662606
    [Abstract] [Full Text] [Related]

  • 18. Biological monitoring of tetrahydrofuran: contribution of a physiologically based pharmacokinetic model.
    Droz PO, Berode M, Jang JY.
    Am Ind Hyg Assoc J; 1999 Feb 15; 60(2):243-8. PubMed ID: 10222575
    [Abstract] [Full Text] [Related]

  • 19. Biological monitoring of workers exposed to low levels of 2-butoxyethanol.
    Haufroid V, Thirion F, Mertens P, Buchet JP, Lison D.
    Int Arch Occup Environ Health; 1997 Feb 15; 70(4):232-6. PubMed ID: 9342622
    [Abstract] [Full Text] [Related]

  • 20. Incorporation of therapeutic interventions in physiologically based pharmacokinetic modeling of human clinical case reports of accidental or intentional overdosing with ethylene glycol.
    Corley RA, McMartin KE.
    Toxicol Sci; 2005 May 15; 85(1):491-501. PubMed ID: 15716481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.